ACRP Partners with Shanghai Clinical Research Center

Thursday, December 11, 2008 09:10 AM

The Association of Clinical Research Professionals (ACRP) has partnered with the Shanghai Clinical Research Center (SCRC) to promote ACRP training and certification throughout China.

SCRC will develop multiple ACRP-approved training centers in China, launch an annual national conference and facilitate ACRP Certification Examinations throughout China.  SCRC will also license its ready-made training course to ACRP.

“China has increasingly played an important role in clinical research in recent years,” said Dr. Gan Rongxing, SCRC’s CEO, in an ACRP release. “The increasing opportunity for global clinical trials in China requires more physician investigators, clinical research associates, and clinical research coordinators with professional skills. The cooperation between SCRC and ACRP targets these market demands, and will quickly bring the international experience to China.”

An ACRP trainer recently spent a week in Shanghai teaching a Good Clinical Practice course for physicians. The organizations will offer ACRP Certification Exam Review courses in early 2009 in preparation for the March certification exam.

Founded in 1976, Alexandria, Va.-based ACRP is a 20,000-member nonprofit association for clinical researchers. The organization has global chapters in Australia, Belgium, Canada, Africa, Germany, India, Israel, Japan, Netherlands, Serbia, Singapore, Taiwan and the UK.

“ACRP weighed, over a two-year period, a number of potential alliance partners in China. We believe that the strong backing of the Shanghai government positions SCRC to be at the forefront in developing education for the Clinical Research Team in China,” said ACRP President and CEO Thomas L. Adams in the association’s release.

Share:          
CWWeekly

May 21

Parexel consultant testifies on FDA biosimilars guidance

Global Telecom Testing checks ex-U.S. toll-free phone lines for multinational clinical trials

To read the full articles for this issue of CWWeekly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

CWWeekly

May

Newer sites most optimistic about the future
Investigative sites of all sizes, from part-time physician-run sites to large dedicated research centers, report a rebound in operating conditions, according to a new CenterWatch analysis, yet sites from each subgroup indicate they have concerns…

Risk-based monitoring slow to catch on with industry
It's estimated that the cost of physically sending monitors to all investigative sites at regular intervals, a model the industry itself developed and has adhered to for about a decade, eats up one-third to one-half of…

Eye On Millennium
Millennium, The Takeda Oncology Company, discovers and develops novel treatments applying world-class recombinant technology to a wide variety of oncology disease targets…

To read the full articles for this issue of The CenterWatch Monthly, please click here for subscription information.

Already a digital subscriber? Access this issue now.

JobWatch centerwatch.com/jobwatch

Featured Jobs